(Q34960559)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

main subject

irritable bowel syndrome

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Piero Portincasa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Leonilde Bonfrate

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jan Tack

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Ignazio Grattagliano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

1 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Gastroenterology

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

995-1009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964766%20AND%20SRC:MED&resulttype=core&format=json

Interspecies interactions within oral microbial communities

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Intestinal microbiota in human health and disease: the impact of probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Factors influencing the composition of the intestinal microbiota in early infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The intestinal microbiota in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The human microbiome project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Gut microbiota and probiotics in maternal and infant health.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Longitudinal investigation of the faecal microbiota of healthy full-term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Establishment of the gut microbiota in Western infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Succession of microbial consortia in the developing infant gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Development of the human infant intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

In vivo and in vitro models of the human colonic flora

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Gut Microbiota in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Diversity of the human gastrointestinal tract microbiota revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

A simplified recipe for prions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Single-cell identification in microbial communities by improved fluorescence in situ hybridization techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Identification of glucose-fermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The NIH Human Microbiome Project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Towards the human intestinal microbiota phylogenetic core

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Microbial communities in the human small intestine: coupling diversity to metagenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Microflora modulation of motility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Gut flora in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The degree of microbiome complexity influences the epithelial response to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The interaction between bacteria and bile.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Bile salt biotransformations by human intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Role of bile acids and bile acid receptors in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Colonic health: fermentation and short chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Gut microbiome, obesity, and metabolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Induction of colonic regulatory T cells by indigenous Clostridium species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Induction of intestinal Th17 cells by segmented filamentous bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Modulation of gut mucosal biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Review article: the role of butyrate on colonic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Voices from within: gut microbes and the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Principles and clinical implications of the brain-gut-enteric microbiota axis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Reduced anxiety-like behavior and central neurochemical change in germ-free mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Normal gut microbiota modulates brain development and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Bacterial infection causes stress-induced memory dysfunction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

On communication between gut microbes and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

AGA technical review on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The irritable bowel syndrome: a paroxysmal motor disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Ambulatory 24-hour jejunal motility in diarrhea-predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Visceral hypersensitivity following cold water intake in subjects with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Repetitive rectal painful distention induces rectal hypersensitivity in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Immune activation in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Postinfectious irritable bowel syndrome--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The genetics of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Microbial community and metabolomic comparison of irritable bowel syndrome faeces

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Abnormal colonic fermentation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Probiotics in irritable bowel syndrome: an immunomodulatory strategy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Probiotics-host communication: Modulation of signaling pathways in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Alterations in the intestinal microbiota and functional bowel symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Review article: prebiotics in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Rifaximin therapy for patients with irritable bowel syndrome without constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meetingROMEII criteria for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Fecal microbiota transplantation and emerging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Fecal microbiota transplantation: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Bacteriotherapy using fecal flora: toying with human motions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220

The microbiome-gut-brain axis: from bowel to behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.799220